Table 4.
Values of the MLR and NLR for AKI by multivariate logical regression analysis.
| Variables | Unadjusted |
Adjusted |
||
|---|---|---|---|---|
| OR (95% CI) | p-value | OR (95% CI) | p-value | |
| MLR | 4.007 (1.772, 9.06) | <0.001 | 3.904 (1.623, 9.391) | <0.001* |
| NLR | 1.161 (1.137, 1.186) | <0.001 | 1.161 (1.135, 1.187) | <0.001* |
| CRP (mg/L) | 1.005 (1.004, 1.007) | <0.001 | 1.004 (1.003, 1.006) | <0.001* |
| PCT (ng/mL) | 1.026 (1.020, 1.032) | <0.001 | 1.025 (1.019, 1.031) | <0.001* |
| CombindMLR + NLR | 1.394 (1.344, 1.446) | <0.001 | 1.377 (1.325, 1.431) | <0.001* |
| Hemoglobin (g/L) | 0.996 (0.993, 1.000) | 0.038 | 0.996 (0.992, 1.000) | 0.039* |
| Albumin (g/L) | 0.954 (0.939, 0.969) | <0.001 | 0.953 (0.937, 0.970) | <0.001* |
| Triglyceride (mmol/L) (mmol/L) (mmol/L) | 1.090 (1.028, 1.157) | 0.004 | 1.087 (1.022, 1.156) | 0.008* |
| APACHE II | 1.092 (1.075, 1.109) | <0.001 | 1.079 (1.060, 1.097) | <0.001* |
*Adjusted for age, sex, malignancies, severe liver disease, rheumatism, acute infection, shock, acute pancreatitis, hematologic disease, baseline Scr, diabetes mellitus, coronary artery disease, hypertension, and chronic obstructive pulmonary disease.
APACHEII: acute physiology and chronic health evaluation II; CI: confidence interval; CRP: C-reactive protein; MLR: monocyte-to-lymphocyte ratio; NLR: neutrophil-to-lymphocyte ratio; OR: odds ratio; PCT: procalcitonin; PLR: platelet-to-lymphocyte ratio.